DEBORAH  SCHADY  to  Clinical Trials, Phase I as Topic
                            
                            
                                This is a "connection" page, showing publications  DEBORAH  SCHADY  has written about  Clinical Trials, Phase I as Topic.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.058
         
        
        
     
 
    
        
        - 
            Hyperleukocytosis in a neuroblastoma patient after treatment with natural killer T cells expressing a GD2-specific chimeric antigen receptor and IL-15. J Immunother Cancer. 2025 Jan 11; 13(1).
            
            
                Score: 0.058